Pharmaceutical

Otsuka Reports Positive Phase 3 VISIONARY Two-Year eGFR Results for VOYXACT in IgAN

articleOtsuka Holdings Co., Ltd.July 1, 20264/news/otsuka-reports-positive-phase-3-visionary-two-year-egfr-results-for-voyxact-in-igan

About this update from Otsuka Holdings Co., Ltd.

Otsuka Holdings Co., Ltd. (4578) Press ReleaseView Attachment